Elisabetta Terruzzi
- Hematology top 5%
- Public Health, Environmental and Occupational Health top 10%
- Oncology
- Genetics
- Pathology and Forensic Medicine
- Co-authors
- Enrico Maria PoglianiAlessandro RambaldiMatteo ParmaEmanuele AngelucciClaudio RomaniDaniele MatteiGiuseppe RossiTamara Intermesoli
- Topics
- Acute Lymphoblastic Leukemia research (9 papers)Chronic Myeloid Leukemia Treatments (6 papers)Lymphoma Diagnosis and Treatment (5 papers)
- Partner nations
- ItalyGermanyUnited States
In The Last Decade
Elisabetta Terruzzi
19 papers receiving 419 citations
Peers
Comparison fields: 5 of 57
- Hematology 284
- Public Health, Environmental and Occupational Health 198
- Oncology 142
- Genetics 77
- Pathology and Forensic Medicine 63
Countries citing papers authored by Elisabetta Terruzzi
This map shows the geographic impact of Elisabetta Terruzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Terruzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Terruzzi more than expected).
Fields of papers citing papers by Elisabetta Terruzzi
This network shows the impact of papers produced by Elisabetta Terruzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Terruzzi. The network helps show where Elisabetta Terruzzi may publish in the future.
Co-authorship network of co-authors of Elisabetta Terruzzi
This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Terruzzi. A scholar is included among the top collaborators of Elisabetta Terruzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Terruzzi. Elisabetta Terruzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 2 | |
| 3 | 13 | |
| 4 | 4 | |
| 5 | 15 | |
| 6 | 10 | |
| 7 | 2 | |
| 8 | 34 | |
| 9 | 0 | |
| 10 | 182 | |
| 11 | 69 | |
| 12 | Short-course imatinib (IM) added to chemotherapy improves early but not long-term outcome in adult Ph/BCR-ABL+ acute lymphoblastic leukemia (ALL) : 5-year follow-up results of study NILG-09 | 4 |
| 13 | 1 | |
| 14 | 11 | |
| 15 | 6 | |
| 16 | 1 | |
| 17 | 28 | |
| 18 | 3 | |
| 19 | 12 | |
| 20 | 16 |
About Elisabetta Terruzzi
Elisabetta Terruzzi is a scholar working on Health Informatics, Hematology and Genetics, having authored 20 papers that have together received 426 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Hematology (284 citations), Genetics (77 citations) and Public Health, Environmental and Occupational Health (198 citations). Elisabetta Terruzzi has collaborated with scholars based in Italy, Germany and United States. Frequent co-authors include Enrico Maria Pogliani, Alessandro Rambaldi, Matteo Parma, Emanuele Angelucci, Claudio Romani, Daniele Mattei, Giuseppe Rossi, Tamara Intermesoli, Alessandro Levis and Elena Oldani. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.